Magenta inks deal with Heidelberg to add new ADCs to its transplant palette – FierceBiotech
FierceBiotech |
Magenta inks deal with Heidelberg to add new ADCs to its transplant palette
FierceBiotech The two companies will combine Magenta's stem cell expertise with Heidelberg's ATAC platform to develop ADCs loaded with a toxin (amanitin) against four undisclosed cellular targets. (rawpixel via Unsplash). Share Facebook Twitter LinkedIn Email Print … Magenta, Heidelberg Pharma Launch Bone Marrow Transplant ADC Collaboration |
